Death of a Pop Star is one of Webtoon's most beloved ongoing supernatural romantic comedies, and it's getting a physical ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 36.07% higher than today’s price of $756.99.

Gone are the days when you have to watch illegally uploaded anime episodes, cut into nine parts, and uploaded onto five different anime YouTube channels. Forget about ...

The FDA ap­proved Eli Lil­ly’s Omvoh in Crohn’s dis­ease, the com­pa­ny an­nounced Wednes­day, hand­ing the drug its sec­ond in­di­ca­tion af­ter giv­ing it a green light … ...

From exciting original anime to adaptations, 2025 has more than enough anime to keep you occupied. Every year is a pretty good year for anime, as the Japanese animation industry regularly churns ...

Your browser does not support the audio element. At Paste, we believe there’s an anime for everyone. With lists like this, diverse demographics are often left ...

Wondering about the best anime games to play in 2025? Well, you aren't alone. With crossovers with the top JRPGs and nail-biting visual novels, the greatest anime games never fail to grip our ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 revenue guidance, which fell short of Wall Street expectations. The ...

Lilly plans to share its full Q4 2024 results on 6 February 2025. Credit: JHVEPhoto via Getty Images. Eli Lilly has announced a $400m reduction in its 2024 revenue forecast, marking a 3% shortfall ...